Clinical outcome of Yttrium-90 selective internal radiation therapy (Y-90 SIRT) in unresectable hepatocellular carcinoma: Experience from a tertiary care center

Clinical outcome of Yttrium-90 selective internal radiation therapy (Y-90 SIRT) in unresectable hepatocellular carcinoma: Experience from a tertiary care center

Background and aim: Whereas Yttrium-90 selective internal radiation therapy (Y-90 SIRT) was shown to improve local tumor control in non-Asian population, the efficacy of this therapy for Asian population in real-world setting remains poorly detailed. We aimed to determine outcomes and identify predi...

Full description

Bibliographic Details
Main Authors: Jukkaphop Chaikajornwat, Wasu Tanasoontrarat, Chonlada Phathong, Nutcha Pinjaroen, Roongruedee Chaiteerakij
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2022-03-01
Series:Liver Research
Subjects:
Liver cancer
Survival outcome
Transarterial radioembolization (TARE)
Unresectable hepatocellular carcinoma
Yttrium-90 selective internal radiation therapy (Y-90 SIRT)
Online Access:http://www.sciencedirect.com/science/article/pii/S2542568421000441

Internet

http://www.sciencedirect.com/science/article/pii/S2542568421000441

Similar Items